About Dr. Chen Xiangping
Dr. Chen Xiangping (陈向平) is the Director of the Department of Rhinology at the Eye & ENT Hospital of Fudan University — China's leading specialized ENT institution and the national reference center for rhinological diseases. One of China's foremost rhinologists, Dr. Chen specializes in the endoscopic surgical management of chronic rhinosinusitis, nasal polyps, skull base tumors, and sinonasal malignancies, with particular expertise in functional endoscopic sinus surgery (FESS), extended endoscopic skull base approaches, and the management of refractory sinonasal disease.
Dr. Chen is known for his technical precision in endoscopic surgery, his commitment to preserving nasal function while achieving complete disease clearance, and his leadership in developing minimally invasive approaches to conditions that previously required open craniofacial surgery. His department is a national referral destination for complex rhinological cases including recurrent nasal polyps after failed surgery, inverted papilloma, juvenile nasopharyngeal angiofibroma, and anterior skull base tumors accessible via the endoscopic endonasal route.
Hospital Affiliation
The Eye & ENT Hospital of Fudan University is China's only specialized hospital dedicated exclusively to ophthalmology and otolaryngology, consistently ranked as the nation's top ENT institution. Its Department of Rhinology is a National Key Clinical Specialty and operates dedicated clinics for chronic rhinosinusitis, allergic rhinitis, nasal polyposis, smell disorders, and sinonasal tumors.
The department is equipped with state-of-the-art endoscopic imaging systems, intraoperative navigation (image-guided surgery), and advanced allergy testing capabilities. Its close integration with the hospital's otology, laryngology, and head & neck surgery departments enables comprehensive multidisciplinary management of complex sinonasal and skull base conditions. The rhinology team also collaborates closely with neurosurgery for extended endoscopic skull base procedures involving the anterior and middle cranial fossa.
Clinical Expertise
- Chronic rhinosinusitis (CRS) — CRS with and without nasal polyps; eosinophilic CRS; recurrent CRS after prior surgery; biologic therapy (dupilumab, mepolizumab) coordination
- Functional endoscopic sinus surgery (FESS) — primary and revision FESS; image-guided surgery; Draf III (modified Lothrop) frontal sinus procedure; sphenoid sinus surgery
- Nasal polyps — medical and surgical management; biologic therapy for refractory polyposis; recurrence prevention strategies
- Allergic rhinitis — comprehensive allergy testing; allergen immunotherapy; pharmacological management; surgical options for turbinate hypertrophy
- Sinonasal tumors — inverted papilloma; juvenile nasopharyngeal angiofibroma (JNA); sinonasal undifferentiated carcinoma; esthesioneuroblastoma; endoscopic resection and reconstruction
- Endoscopic skull base surgery — anterior skull base tumors; pituitary adenoma (with neurosurgery); CSF leak repair; meningoencephalocele; orbital decompression
- Smell & taste disorders — post-viral anosmia (including post-COVID); post-traumatic anosmia; olfactory training; sinonasal cause evaluation
- Epistaxis — recurrent nosebleeds; hereditary hemorrhagic telangiectasia (HHT); endoscopic arterial ligation
- Nasal septal deviation & turbinate surgery — septoplasty; inferior turbinate reduction; nasal valve repair
- Nasopharyngeal diseases — nasopharyngeal cysts; adenoid hypertrophy in adults; post-nasopharyngeal carcinoma surveillance
Academic & Research Contributions
Dr. Chen Xiangping has authored numerous peer-reviewed publications in leading rhinology and ENT journals including the International Forum of Allergy & Rhinology, Rhinology, The Laryngoscope, and the European Archives of Oto-Rhino-Laryngology. His research focuses on the pathogenesis and treatment of eosinophilic chronic rhinosinusitis, the outcomes of endoscopic skull base surgery, and the application of biologic therapies for refractory nasal polyposis in Chinese patients.
He is an active member of the Chinese Society of Otorhinolaryngology's Rhinology Group and has contributed to the development of national clinical guidelines for chronic rhinosinusitis and nasal polyps. Dr. Chen has served as principal investigator on clinical trials evaluating biologic therapies for CRS with nasal polyps and is a regular presenter at the European Rhinologic Society (ERS) Congress and the American Rhinologic Society (ARS) annual meeting.
His work on the epidemiology and phenotyping of chronic rhinosinusitis in Chinese patients — which differs significantly from Western populations in its higher prevalence of eosinophilic disease and distinct cytokine profiles — has been particularly influential, providing data that informs both domestic and international treatment guidelines. Dr. Chen has also pioneered the use of intraoperative navigation for complex revision sinus surgery at Fudan's Eye & ENT Hospital, significantly improving safety outcomes in high-risk cases.
Why International Patients Choose Dr. Chen Xiangping
International patients seek Dr. Chen's expertise for revision sinus surgery after failed procedures abroad, management of refractory nasal polyps that have not responded to medical therapy, access to biologic treatments for CRS at significantly lower cost than in Western countries, and endoscopic resection of sinonasal tumors including inverted papilloma and skull base lesions.
Post-COVID anosmia is an increasingly common reason for international patients to seek rhinological consultation at Fudan's Eye & ENT Hospital, where Dr. Chen's team offers comprehensive olfactory evaluation and structured olfactory training programs. For patients who have lost their sense of smell following COVID-19 infection, this specialized assessment can identify treatable sinonasal causes and guide rehabilitation strategies.
The cost advantage is substantial: FESS, revision sinus surgery, and biologic therapy for nasal polyps are available at Fudan's Eye & ENT Hospital at a fraction of the cost of equivalent treatment in the United States or Europe, without compromising on surgical expertise or drug quality.
What to Expect at Your Consultation
Consultations with Dr. Chen begin with a comprehensive rhinological history, nasal endoscopy, and review of prior CT sinus imaging and treatment records. CMCS will arrange certified translation of all medical records in advance. Where additional imaging — including CT sinuses, MRI for soft tissue assessment, or allergy testing — is needed, this can typically be arranged within 24–48 hours. Dr. Chen will provide a detailed management plan including medical therapy optimization, surgical planning where indicated, and biologic therapy recommendations — all summarized in English for your home ENT surgeon or allergist.
Frequently Asked Questions
I've had sinus surgery before but my polyps keep coming back. Can Dr. Chen help?
Yes. Recurrent nasal polyps after prior surgery are one of Dr. Chen's core specialties. He will assess the underlying inflammatory phenotype, optimize medical therapy including biologic agents, and plan revision surgery where appropriate using image-guided navigation for maximum safety.
Is dupilumab available for nasal polyps at Fudan Eye & ENT Hospital?
Yes. Dupilumab and other biologic therapies approved for CRS with nasal polyps are available at significantly lower cost than in Western markets, making Shanghai an attractive destination for patients managing long-term biologic therapy.
Can Dr. Chen treat post-COVID smell loss?
Yes. The department offers comprehensive olfactory evaluation including smell testing, nasal endoscopy, and MRI of the olfactory bulbs where indicated, followed by a structured olfactory training and medical management program.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking rhinology care with Dr. Chen Xiangping at the Eye & ENT Hospital of Fudan University, including priority appointment scheduling, certified medical translation, imaging coordination, and post-consultation follow-up. Contact us at contract@medicalsh.com, WeChat: gezhanglao, or visit medicalsh.com.
0 則留言